Crossmark

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

Crossref DOI link: https://doi.org/10.1038/s41591-019-0437-z

Published Online: 2019-05-08

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dedrick, Rebekah M.

Guerrero-Bustamante, Carlos A.

Garlena, Rebecca A.

Russell, Daniel A.

Ford, Katrina

Harris, Kathryn

Gilmour, Kimberly C.

Soothill, James

Jacobs-Sera, Deborah

Schooley, Robert T.

Hatfull, Graham F. http://orcid.org/0000-0002-6705-6821
Spencer, Helen http://orcid.org/0000-0003-2474-3290
License Information

Text and Data Mining valid from 2019-05-01
More Information

Article History

Received: 14 January 2019

Accepted: 27 March 2019

First Online: 8 May 2019

Competing interests

: R.T.S. serves as an uncompensated member of the AmpliPhi Scientific Advisory Board. Other authors declare no competing interests.